Last reviewed · How we verify
HR011408 injection
At a glance
| Generic name | HR011408 injection |
|---|---|
| Sponsor | Jiangsu HengRui Medicine Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparison of HR011408 and NovoRapid® in Subjects With Diabetics (PHASE1)
- The Pharmacokinetics and Pharmacodynamics Between HR011408 and NovoRapid® in Healthy Subject (PHASE1)
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HR011408 at Two Formulations in Healthy Subject (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |